News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.
Isogenica’s
Latest News
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology
Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology. Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.Isogenica Ltd and Fusion...
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.
Events
Resources
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
Advantages of using VHH antibodies for CAR engineering
We explain the advantages of VHHs for CAR ectodomain targeting relative to traditional scFvs including size, solubility, and VHHs unique “magic finger” CDR3 domain.
Neurodegenerative Diseases
The advantages of VHH in Neurodegenerative Diseases.
Webinars
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Isogenica’s
Newsletters
Catch up with Isogenica’s news and activies through the latest Newsletters.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.